INVITRO SUSCEPTIBILITIES OF SUCROSE-NEGATIVE CANDIDA-TROPICALIS, CANDIDA-LUSITANIAE, AND CANDIDA-NORVEGENSIS TO AMPHOTERICIN-B, 5-FLUOROCYTOSINE, MICONAZOLE, AND KETOCONAZOLE

被引:31
作者
AHEARN, DG
MCGLOHN, MS
机构
关键词
D O I
10.1128/JCM.19.3.412-416.1984
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:412 / 416
页数:5
相关论文
共 16 条
[11]   CHARACTERIZATION OF ATYPICAL CANDIDA-TROPICALIS AND OTHER UNCOMMON CLINICAL YEAST ISOLATES [J].
SCHLITZER, RL ;
AHEARN, DG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (03) :511-516
[12]   PRIMARY SITE OF ACTION OF KETOCONAZOLE ON CANDIDA-ALBICANS [J].
UNO, J ;
SHIGEMATSU, ML ;
ARAI, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (06) :912-918
[13]  
VANCUTSEM J, 1981, MYKOSEN, V24, P596
[14]   INVITRO AND INVIVO EFFECTS OF THE ANTI-MYCOTIC DRUG KETOCONAZOLE ON STEROL SYNTHESIS [J].
VANDENBOSSCHE, H ;
WILLEMSENS, G ;
COOLS, W ;
CORNELISSEN, F ;
LAUWERS, WF ;
VANCUTSEM, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) :922-928
[15]  
VANDENBOSSCHE H, 1975, SABOURAUDIA, V13, P63
[16]   CANDIDA-TROPICALIS - MAJOR PATHOGEN IN IMMUNOCOMPROMISED PATIENTS [J].
WINGARD, JR ;
MERZ, WG ;
SARAL, R .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (04) :539-543